Business EconomyPosted at: Dec 5 2025 8:43PM


Lupin gets US FDA approval for multiple sclerosis tablet

Chennai, Dec 5 (UNI) Pharmaceutical major Lupin Ltd on Friday announced that it has received tentative approval from the United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application for Siponimod Tablets, 0.25 mg, 1 mg, and 2 mg.
This product would be manufactured at Lupin’s Pithampur facility in India.
Siponimod Tablets, 0.25 mg, 1 mg, and 2 mg are bioequivalent to Mayzent Tablets, 0.25 mg, 1 mg, and 2 mg of Novartis Pharmaceuticals Corporation, and indicated for the treatment of relapsing forms of Multiple Sclerosis (MS), to include clinically isolated syndrome, relapsing remitting disease, and active secondary progressive disease, in adults.
Siponimod Tablets (RLD Mayzent) had estimated annual sales of USD 195 million in the US, the company said.
UNI VJ VAN RKM
Please log in to get detailed story.
Tags: #Lupin gets US FDA approval for multiple sclerosis tablet
More News

Godrej incorporates subsidiary to enhance financial services presence

14 Jan 2026 | 8:03 PM

Mumbai, Jan 14 (UNI) Godrej Industries Ltd (GIL) has officially announced that it has incorporated a new subsidiary, called Godrej Investment Ltd, as its financial services arm, which will serve as an umbrella holding company for all group financial operations, including its lending businesses.

see more..

Large-Ticket Deals Power Industrial & Warehousing Leasing to 36 9 Mn Sq Ft in 2025: Colliers

14 Jan 2026 | 7:59 PM

Hyderabad, Jan 14( UNI) India’s industrial and warehousing real estate market recorded its strongest performance in recent years, with 36.9 million sq ft of leasing in 2025, registering a 16% year-on-year growth, according to a report released by Colliers India.

see more..

14 Jan 2026 | 7:35 PM

Hyderabad, Jan 14 UNI) : Capital inflows into India’s real estate sector rose sharply in calendar year 2025, reaching an all-time high of USD 14.3 billion, marking a 25 per cent year-on-year growth, according to a latest report ‘ India market Monitor Q4 2025- Investments’ released by CBRE South Asias Pvt Ltd.

see more..

Cyient founder Mohan Reddy receives living leged award by Geospatial World

14 Jan 2026 | 7:18 PM

Hyderabad, Jan 14 (UNI) Cyient, a global Intelligent Engineering solutions company, on Wednesday announced that its Founder Chairman, Dr. B.V.R. Mohan Reddy, has been conferred the ‘Living Legend Award’ by Geospatial World, one of the world’s leading geospatial knowledge organisations.

see more..

Dr Reddy’s launches first to market OTC antihistamine eye drop in US

14 Jan 2026 | 6:54 PM

Hyderabad, Jan 14 (UNI) : Dr. Reddy’s Laboratories on Wednesday announced the first-to-market U.S. launch of Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC), the generic equivalent of Extra-Strength Pataday® Once-Daily Relief, following approval by the U.S. Food and Drug Administration.

see more..